•  
  •  
  •  
  •  

2025-10-04 02:18:50

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand

Keywords Selected:  AartiDrugs

Stock Report

  • Aarti Drugs Limited receives order from MPCB for closure of process at Tarapur unit
  • Aarti Drugs Ltd posts consolidated Q1FY26 net profit of Rs. 53.91 crores
  • Aarti Drugs Ltd Q4 FY2025 consolidated PAT climbs to Rs. 62.86 crores
  • Aarti Drugs Ltd receives EIR from USFDA for Tarapur API facility
  • Aarti Drugs Ltd Q2 FY2025 consolidated profit at Rs. 35.01 crores
  • Aarti Drugs Ltd's subsidiary receives CGMP certificate from UK MHRA
  • Aarti Drugs Ltd receives Form 483 with 7 observations from USFDA after inspection at API facility
  • Pinnacle Life Science Pvt Ltd receives EIR from USFDA for Baddi facility
  • Aarti Drugs Ltd Q1 FY2024-25 consolidated PAT falls to Rs. 33.24 crores
  • Aarti Drugs Ltd posts Rs. 47.37 crores consolidated profit in Q4 FY24
  • Aarti Drugs Ltd posts consolidated PAT of Rs. 36.71 crores in Q3 FY2024
  • Aarti Drugs Ltd Q2 FY2024 consolidated net profit drops QOQ to Rs. 39.59 crores
  • Aarti Drugs Ltd board approves buy back through tender offer
  • Aarti Drugs Ltd consolidated Q1FY24 net profit at Rs. 47.85 crores
  • Aarti Drugs Limited wins Pharmexcil Outstanding Exports Awards 2021-22
  • Aarti Drugs Ltd Q4 FY23 consolidated PAT up at Rs. 56.18 crores
  • Aarti Drugs Ltd declares interim dividend of Rs. 1
  • Aarti Drugs Ltd Q3 FY2023 consolidated net profit lower at Rs. 36.68 crores
  • Aarti Drugs Ltd posts consolidated PAT of Rs. 38.75 crores in Q2FY23
  • Aarti Drugs Ltd reports consolidated Q1 FY2022-23 net profit lower at Rs. 34.78 crores
  • Aarti Drugs posts consolidated Q4FY22 net profit of Rs. 55.34 crores
  • Aarti Drugs Ltd declares interim dividend of Rs. 1
  • Aarti Drugs posts consolidated PAT of Rs. 58.29 crores in Q3 FY22
  • Aarti Drugs Ltd reports consolidated PAT of Rs. 42.59 crore in Q2 FY2021-22

Latest Post

  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024